Zealand Pharma A/S (0NZU.IL)
Develops injectable drugs treating severe low blood sugar and digestive disorders.
305.60-0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-6.6%
The outlook
Zealand Pharma trades near 305.6 DKK, sitting in the lower portion of its 52-week range after a mixed performance against moving averages. Analyst sentiment leans bearish, and the stock shows little momentum today. Current positioning suggests caution among market observers.
What’s behind the score
Price trendMixed vs its moving averages
52-week range22% of the way from its 52-week low to high
Market cap
$18.22B
52-wk high
555.30
52-wk low
233.20
50-day avg
298.00
200-day avg
371.95
Trailing P/E
—